This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Finland, France, Hong Kong SAR China, Ireland, New Zealand, Poland, Romania, Singapore, South Africa, Spain, Turkey, UK.
The drug MULTIHANCE contains one active pharmaceutical ingredient (API):
1
|
UNII
3Q6PPC19PO - GADOBENATE DIMEGLUMINE
|
|
Gadobenic acid is a paramagnetic contrast agent for use in diagnostic magnetic resonance imaging (MRI) of the liver. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| MULTIHANCE Solution for injection | MPI, EU: SmPC | Medicines & Healthcare Products Regulatory Agency (GB) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V08CA08 | Gadobenic acid | V Various → V08 Contrast media → V08C Magnetic resonance imaging contrast media → V08CA Paramagnetic contrast media |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| BR | Câmara de Regulação do Mercado de Medicamentos | 559219070003002, 559219070003102, 559219070003202 |
| CA | Health Products and Food Branch | 02248302 |
| ES | Centro de información online de medicamentos de la AEMPS | 66373, 71048 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 054240, 054252, 054263, 054274, 098098, 145830, 440519 |
| FR | Base de données publique des médicaments | 62924107, 67189273 |
| GB | Medicines & Healthcare Products Regulatory Agency | 115443 |
| HK | Department of Health Drug Office | 57789 |
| HR | Agencija za lijekove i medicinske proizvode | HR-H-872900882 |
| NZ | Medicines and Medical Devices Safety Authority | 10784 |
| PL | Rejestru Produktów Leczniczych | 100106089 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W58842001, W58842002, W58842003, W58842004 |
| SG | Health Sciences Authority | 12504P, 12505P, 12506P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699564773448, 8699564773455, 8699564773462, 8699564773479 |
| US | FDA, National Drug Code | 0270-5164, 0270-5264 |
| ZA | Health Products Regulatory Authority | 35/2.9/0086 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.